| 1 |
Chan EW, Zhao J, Chan JC, Zhang C, Feng YB. Introduction to drug-induced liver injury. Comprehensive Guide to Hepatitis Advances 2023. [DOI: 10.1016/b978-0-323-98368-6.00011-2] [Reference Citation Analysis]
|
| 2 |
Yang Y, Ge F, Tang J, Qin S, Zeng R, Yao M, Xiao X, Bai Z, Tang C. A review of herb-induced liver injury in mainland china. Front Pharmacol 2022;13:813073. [DOI: 10.3389/fphar.2022.813073] [Reference Citation Analysis]
|
| 3 |
Bai Z, Tao W, Zhou Y, Cao Y, Yu S, Shi Z. Xiao-Yao-San protects against anti-tuberculosis drug-induced liver injury by regulating Grsf1 in the mitochondrial oxidative stress pathway. Front Pharmacol 2022;13:948128. [DOI: 10.3389/fphar.2022.948128] [Reference Citation Analysis]
|
| 4 |
Jiang HY, Gao HY, Li J, Zhou TY, Wang ST, Yang JB, Hao RR, Pang F, Wei F, Liu ZG, Kuang L, Ma SC, He JM, Jin HT. Integrated spatially resolved metabolomics and network toxicology to investigate the hepatotoxicity mechanisms of component D of Polygonum multiflorum Thunb. J Ethnopharmacol 2022;298:115630. [PMID: 35987407 DOI: 10.1016/j.jep.2022.115630] [Reference Citation Analysis]
|
| 5 |
Wang M, Zhang Z, Ruan P, Zhang G, Xiao C, Wang Y, Gao Y. Emodin-induced hepatotoxicity is enhanced by 3-methylcholanthrene through activating aryl hydrocarbon receptor and inducing CYP1A1 in vitro and in vivo. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.110089] [Reference Citation Analysis]
|
| 6 |
Rodriguez-Diaz C, Taminiau B, García-García A, Cueto A, Robles-Díaz M, Ortega-Alonso A, Martín-Reyes F, Daube G, Sanabria-Cabrera J, Jimenez-Perez M, Isabel Lucena M, Andrade RJ, García-Fuentes E, García-Cortes M. Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury. Pharmacol Res 2022;182:106348. [PMID: 35817360 DOI: 10.1016/j.phrs.2022.106348] [Reference Citation Analysis]
|
| 7 |
Nunes DRDCMA, Monteiro CSDJ, dos Santos JL. Herb-Induced Liver Injury—A Challenging Diagnosis. Healthcare 2022;10:278. [DOI: 10.3390/healthcare10020278] [Reference Citation Analysis]
|
| 8 |
Teschke R, Danan G. Causality Assessment in Pharmacovigilance for Herbal Medicines. Pharmacovigilance for Herbal and Traditional Medicines 2022. [DOI: 10.1007/978-3-031-07275-8_10] [Reference Citation Analysis]
|
| 9 |
Caballano-infantes E, García-garcía A, Lopez-gomez C, Cueto A, Robles-diaz M, Ortega-alonso A, Martín-reyes F, Alvarez-alvarez I, Arranz-salas I, Ruiz-cabello F, Lucena IM, García-fuentes E, Andrade RJ, García-cortes M. Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury. Biomedicines 2022;10:55. [DOI: 10.3390/biomedicines10010055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 10 |
Zhai XR, Zou ZS, Wang JB, Xiao XH. Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics. Front Pharmacol 2021;12:738577. [PMID: 34539416 DOI: 10.3389/fphar.2021.738577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Teschke R, Xuan TD. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment.Japanese J Gastroenterol Hepatol. 2019;6:1-16. [DOI: 10.21037/tgh-20-149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Chen Y, Wang C, Yang H, Huang P, Shi J, Tong Y, Jiang J, Zhang X, Chen W, Xuan Z. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China. Biomed Res Int 2021;2021:8894498. [PMID: 33954202 DOI: 10.1155/2021/8894498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Teschke R, Danan G. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. Medicines (Basel) 2020;7:E62. [PMID: 33003400 DOI: 10.3390/medicines7100062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 14 |
Teschke R, Zhu Y, Jing J. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases. J Clin Transl Hepatol 2020;8:200-14. [PMID: 32832401 DOI: 10.14218/JCTH.2020.00009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 15 |
Tillmann HL. Hepatotoxicity; Drug-Induced Liver Injury. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65703-3] [Reference Citation Analysis]
|
| 16 |
Bellanger RA, Seeger CM. Complementary and alternative medicine. Side Effects of Drugs Annual 2020. [DOI: 10.1016/bs.seda.2020.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 17 |
Teschke R, Eickhoff A, Brown AC, Neuman MG, Schulze J. Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. Int J Mol Sci 2019;21:E212. [PMID: 31892250 DOI: 10.3390/ijms21010212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Grewal P, Ahmad J. Severe liver injury due to herbal and dietary supplements and the role of liver transplantation. World J Gastroenterol 2019; 25(46): 6704-6712 [PMID: 31857773 DOI: 10.3748/wjg.v25.i46.6704] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 19 |
Philips CA, Augustine P, Rajesh S, Y PK, Madhu D. Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia. J Clin Transl Hepatol 2019;7:263-74. [PMID: 31608219 DOI: 10.14218/JCTH.2019.00024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
